FDA Investigator Matthew M Schuckmann

Matthew M Schuckmann has inspections in 2 countries as of 28 Jul 2023. Matthew M Schuckmann has collaborated with a combined 2231 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
28 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, New Zealand
Adree N Anderson, Ana Paulap Sandee, Andrew A Hoopes, Anthony R Bucks, April L Young, Ashley A Mutawakkil, Azza Talaat, Bei Y He, Brett R Havranek, Brittany D Terhar, Bryan S Roddy, Carl A Huffman, III, Ceisha C Ukatu, Chad W Rice, Charles O'brein, Charles R Cote, RIC, Christine A Harman, PhD, Cody D Rickman, Cynthia M Goudeau, Damaris Y Hernandez, Dandan Wang, PhD, David J Eide, David L Miser, Dawn C Olenjack, Derrionna M Epps, Dewayne E Whitlock, Donald L Myers, Dustin K Hampton, Edward E Lockwood (EEL), Emilio O Escobar, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Erie C Nielsen, Erika V Butler, Gloria J Champagne, Gretchen Lf Trendel, Gwyn G Dickinson, Hector A Carrero, Helen Y Saccone, Hongjian Ding, Ingrid Y Johnson, Jacob G Lutz, Jacqueline Mdiaz Albertine, Jacqueline Mdiaz Albertini, James I Giefer, Janet B Abt, Jazmine N Still, Jeffrey B Moody, Jennifer Cahill, Jill J Tillman, Johnson, Johnsont, Joseph A Piechocki, Joseph R Lambert, Julie V Bailey, Karen C Daugherty, Karen M Montgomery (KMM), Kathleen B Swat, Kellia N Hicks, Kelly K Nachtigal, Ken L Bowers, Kevin D Kallander, Linda F Murphy, Linda K Cline, Lisa L Flores, Loan Chin, Logan T Williams, Margaret A Smithers, Marianela Aponte Cruz, Mary L Schuckmann, Matthew B Casale, Matthew R Sleeter, Matthew Schuckman, Meisha R Sampson, Michael C Zubelewicz, Michele L Obert, Michele Perry Williams, Monica E Murie, Monica M Mcclure, Monica R Murie, Nancy G Schmidt, Norman K Starks, Omotunde O Osunsanmi, Pamela L Vega, Patrick L Wisor, Paula A Trost, Philip J Boston, Ralph H Vocque, Rendall E Barfoot, Richard L Rutherford, Rita K Kabaso, Robert J Ham, Sarah E Rhoades, Scott A Golladay, Shafiq S Ahadi, Shanna R Haden, Sherry G Bous, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sri Ramakrishnaiah Yellela, Srinivas R Chennamaneni, PhD, State Agency, Steven D Kehoe, Steven P Donald, Susan M Jackson, Susanna E Ford, Analyst, Tamara J Umscheid, Tara L Breckenridge, Tara L Greene, Tara L King, Ted L Anderson, Tiara Nbrown Crosen, Torrey M Ward, Veronica Fuentes, MS, Victoria P Quadrini, Vikas Moolchandani, Walsworth, Warren J Lopicka, Wayne D Mcgrath, William C Corley, Xiaohan Cai, PhD, Yiyue Zhang (nmi), PhD, Zi Qiang Gu

Matthew M Schuckmann's Documents

Publish Date Document Type Title
May, 2021 FDA 483 Missouri Analytical Laboratories, Inc. - Form 483, 2021-05-19
June, 2021 FDA 483 S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2021-06-18
February, 2020 FDA 483 S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2020-02-06
March, 2022 EIR Young Dental Manufacturing I, LLC - EIR, 2022-03-25
October, 2021 FDA 483 VI-JON, LLC - Form 483, 2021-10-13
April, 2022 FDA 483 Legacy Pharmaceutical Packaging, LLC - Form 483, 2022-04-27
March, 2022 FDA 483 Response Young Dental Manufacturing I, LLC - Form 483R, 2022-06-01
May, 2021 FDA 483 Marcus Research Laboratory, Inc. - Form 483, 2021-05-14
June, 2022 FDA 483 S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2022-06-17
October, 2021 FDA 483 Response VI-JON, LLC - Form 483R, 2021-11-03
March, 2022 FDA 483 Young Dental Manufacturing I, LLC - Form 483, 2022-03-25
April, 2022 FDA 483 Response Legacy Pharmaceutical Packaging, LLC - Form 483R, 2022-05-17
September, 2022 FDA 483 S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2022-09-14
August, 2021 FDA 483 Aspen API Inc. - Form 483, 2021-08-06
August, 2022 FDA 483 Consolidated Chemical, Inc. DBA CARE-TECH Laboratories, Inc. - Form 483, 2022-08-02
June, 2023 FDA 483 Hospira, Inc. - Form 483, 2023-06-30
July, 2023 FDA 483 Virbac Corporation - Form 483, 2023-07-28
October, 2021 FDA 483 Dynalabs LLC - Form 483, 2021-10-27
January, 2023 FDA 483 Huvepharma, Inc. - Form 483, 2023-01-30
July, 2023 FDA 483 Virbac Corporation - Form 483, 2023-07-28
January, 2024 FDA 483 R.D. Laboratories, Inc. - Form 483, 2024-01-26
March, 2024 FDA 483 Washington University, The - Form 483, 2024-03-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more